Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased

Min Kim1, Magda Sgagias, Xiyun Deng

  • 1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198-6805, USA. minkim@cnmc.org

Insights

Recombinant adenovirus carrying p14ARF (Adp14ARF) inhibited U2OS osteosarcoma cell growth and induced apoptosis. This suggests Adp14ARF gene therapy may treat cancers with wild-type p53 and mutant p14ARF.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • The INK4A/ARF locus is a tumor suppressor gene frequently mutated in human cancers.
  • Understanding p14ARF expression is crucial for cancer research.

Purpose of the Study:

  • To investigate the effects of p14ARF expression in tumor cells using a recombinant adenovirus (Adp14ARF).
  • To assess the potential of Adp14ARF as a cancer gene therapy.

Main Methods:

  • Constructed Adp14ARF to express p14ARF cDNA in U2OS osteosarcoma cells.
  • Assessed protein levels (p53, p21, mdm2, Fas, Fas-L), cell growth, apoptosis (TUNEL, PARP cleavage), and the role of p53.
  • Utilized Fas-L neutralizing antibody (NOK-1) and E6-expressing cell lines.

Main Results:

  • Adp14ARF infection led to high p14ARF expression, increased p53, p21, and mdm2 levels.
  • Significant growth inhibition and increased apoptosis were observed in U2OS cells.
  • p14ARF-induced apoptosis involved the Fas pathway, requiring wild-type p53, but p53 overexpression alone was insufficient.

Conclusions:

  • p14ARF induces apoptosis through mechanisms beyond p53 induction, including the Fas pathway.
  • Adp14ARF holds promise as a gene therapy for human cancers with wild-type p53 and mutant/deleted p14ARF.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...